Pacific Edge goes back to shareholders for another $20m

Pacific Edge goes back to shareholders for another $20m
Paul McBeth
Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. The bladder cancer test maker said it would raise $7 million at 15 cents per share in a placement to institutional investors and customers of local brokers, which was fully underwritten by Forsyth Barr and Jarden. That's a discount to the 16.5 cents the shares closed at yesterday. Trading was halted for the placement. Pacific Edge said it would then raise a further $13 million in a 1-for-4.25 pro-rata renounce...

More Listed Companies

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024
Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024